Outset Medical
About: Outset Medical Inc is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Company generates revenue from the sales of Tablo consoles and related consumables, including Tablo cartridges and accessories.
Employees: 354
0
Funds holding %
of 7,425 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)
118% more call options, than puts
Call options by funds: $159K | Put options by funds: $73K
33% more capital invested
Capital invested by funds: $17.6M [Q3] → $23.4M (+$5.75M) [Q4]
8% less funds holding
Funds holding: 80 [Q3] → 74 (-6) [Q4]
9.95% less ownership
Funds ownership: 50.02% [Q3] → 40.07% (-9.95%) [Q4]
29% less repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 24
29% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 17
Research analyst outlook
We haven’t received any recent analyst ratings for OM.
Financial journalist opinion
Based on 3 articles about OM published over the past 30 days
Neutral
GlobeNewsWire
1 day ago
OUTSET MEDICAL ALERT: Bragar Eagel & Squire, P.C. is Investigating Outset Medical, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
NEW YORK, April 29, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Outset Medical, Inc. (NASDAQ:OM) on behalf of long-term stockholders following a class action complaint that was filed against Outset Medical on August 29, 2024 with a Class Period from August 1, 2022 to August 7, 2024. Our investigation concerns whether the board of directors of Outset Medical have breached their fiduciary duties to the company.
Positive
Zacks Investment Research
1 week ago
Does Outset Medical (OM) Have the Potential to Rally 71.66% as Wall Street Analysts Expect?
The consensus price target hints at a 71.7% upside potential for Outset Medical (OM). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Positive
Zacks Investment Research
4 weeks ago
Wall Street Analysts Predict an 188.63% Upside in Outset Medical (OM): Here's What You Should Know
The consensus price target hints at an 188.6% upside potential for Outset Medical (OM). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Neutral
GlobeNewsWire
1 month ago
Outset Medical Announces One-for-Fifteen Reverse Stock Split
SAN JOSE, Calif., March 18, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset” or the “Company”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced a one-for-fifteen reverse stock split (the “Reverse Stock Split”) of the Company's common stock, par value $0.001, which will become effective at 12:01 a.m. Eastern Time on Thursday, March 20, 2025. The Company's common stock will continue to trade under Outset's existing trading symbol, OM, on the Nasdaq Global Select Market (“Nasdaq”) on a split-adjusted basis when the market opens on Thursday, March 20, 2025, with the new CUSIP number 690145206.
Negative
Zacks Investment Research
2 months ago
Bears are Losing Control Over Outset Medical (OM), Here's Why It's a 'Buy' Now
Outset Medical (OM) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.
Positive
The Motley Fool
2 months ago
3 Cryptocurrencies That Could Be Better Buys Than Bitcoin Right Now
In 2025, Bitcoin (BTC -1.18%) has over-promised and under-delivered. After reaching $100,000 in December, Bitcoin looked like a no-brainer option to soar in value this year.
Neutral
GlobeNewsWire
2 months ago
Outset Medical to Present at the 45th Annual TD Cowen Health Care Conference
SAN JOSE, Calif., Feb. 24, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that members of management will present at the 45th annual TD Cowen Health Care conference on Tuesday, March 4, 2025, at 2:30 p.m.
Neutral
Seeking Alpha
2 months ago
Outset Medical, Inc. (OM) Q4 2024 Earnings Call Transcript
Outset Medical, Inc. (NASDAQ:OM ) Q4 2024 Earnings Conference Call February 19, 2025 5:00 PM ET Company Participants Jim Mazzola - Head of Investor Relations Leslie Trigg - Chair and CEO Nabeel Ahmed - Chief Financial Officer Conference Call Participants Marie Thibault - BTIG Shagun Singh - RBC Capital Markets Suraj Kalia - Oppenheimer Operator Good day, and thank you for standing by. Welcome to the Outset Medical Fourth Quarter 2024 Earnings Conference Call.
Positive
The Motley Fool
2 months ago
Outset Medical: Profitability Path Brightens
Outset Medical (OM 3.52%), the innovator behind the Tablo Hemodialysis System, reported fourth-quarter earnings on Wednesday, Feb. 19, that topped analysts' consensus expectations on top and bottom lines. Fourth-quarter revenue of $29.5 million exceeded the forecasted $28 million, indicating resilience in revenue growth despite market hurdles.
Negative
Zacks Investment Research
2 months ago
Outset Medical, Inc. (OM) Reports Q4 Loss, Tops Revenue Estimates
Outset Medical, Inc. (OM) came out with a quarterly loss of $0.37 per share versus the Zacks Consensus Estimate of a loss of $0.43. This compares to loss of $0.59 per share a year ago.
Charts implemented using Lightweight Charts™